GlucoBalance with Carnitine (Gaby & Wright Formula) 90C May help activate AMPK

298 item(s)
1855

$64.00

Type I & II Diabetes, elevated triglycerides, LDL cholesterol, decreased HDL cholesterol, dysinsulinism, and Syndrome X glucose 

+

NPN: 80041543

Item Code: 1855

Quantity: 90 capsules

Description: Glycemic Formula, Adrenal Support

Indications: AMPK is a master control mechanism for cellular energy homeostasis. It determines body fat composition and has a significant impact on mitochondrial biogenesis, the diabesity spectrum and life span extension in mice models. Formulated for Biotics Research by Jonathan V. Wright, M.D. and Alan R. Gaby, M.D., leaders in the field of nutritional science. For hypo-hyperglycemia (Type I & II Diabetes), elevated triglycerides and LDL cholesterol, decreased HDL cholesterol, dysinsulinism, and Syndrome X; use with ADHS™ and Flax Seed Oil

Ingredients: See Product Label below.

Suggestion: 2-3 capsules two times daily with meals or as directed.

Safety: Note: Insulin-dependent diabetics must monitor their blood sugar levels frequently, since this product will often dramatically reduce blood glucose

References: Additional references:
A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14.
Cheng HH, Lai MH, Hou WC, Huang CL.J Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem. 2004 Mar 10;52( 5):1385-9
Fox CH, Ramsoomair D, Mahoney MC, Carter C, Young B, Graham R. An investigation of hypomagnesemia among ambulatory urban African Americans. J Fam Pract. 1999 Aug;48( 8):636-9
Shamberger RJ. Calcium, magnesium, and other elements in the red blood cells and hair of normals and patients with premenstrual syndrome. Biol Trace Elem Res. 2003 Aug;94( 2):123-9
Iketani T, Kiriike N, Murray, Stein B, Nagao K, Nagata T, Minamikawa N, Shidao A, Fukuhara H. Effect of menatetrenone ( vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res. 2003 Mar 25;117( 3):259-69
McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004 May 13;350( 20):2042-9
Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res. 1993 Sep;6( 3):247-9
Schiano A, Eisinger F, Detolle P, Laponche AM, Brisou B, Eisinger J. [Silicon, bone tissue and immunity] [Article in French] Rev Rhum Mal Osteoartic. 1979 Jul-Sep;46( 7-9):483-6
Schaafsma A, de Vries PJ, Saris WH. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41( 4):225-49
Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993 Sep;6( 3):291-6
Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9( 2):61-9
Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002 Jun 19; 287( 23): 3127-9
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity ( increased K( m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002 Apr;75( 4):616-58

Product Label (GlucoBalance_1855_90_NEW.png, 539 Kb) [Download]

PDF Attachment (3_Fold_Flyer_-GlucoBalance_Canada~NPN.pdf_LIT-050.pdf, 9,367 Kb) [Download]

PDF Document (LIT-245_-CardioCAN-Print.pdf, 4,327 Kb) [Download]

New Products